These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29080693)

  • 1. S100A12 in renal and cardiovascular diseases.
    Nazari A; Khorramdelazad H; Hassanshahi G; Day AS; Sardoo AM; Fard ET; Abedinzadeh M; Nadimi AE
    Life Sci; 2017 Dec; 191():253-258. PubMed ID: 29080693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A12: Friend or foe in pulmonary tuberculosis?
    Bagheri V
    Cytokine; 2017 Apr; 92():80-82. PubMed ID: 28110121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients.
    Asadikaram G; Noroozi S; Ebrahimi Meimand HA; Sanjari M; Zainodini N; Khoramdelazad H; Shahrokhi N; Kazemi Arababadi M
    Neuroimmunomodulation; 2016; 23(5-6):345-351. PubMed ID: 28433998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
    Oesterle A; Bowman MA
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2496-507. PubMed ID: 26515415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of S100 calcium-binding protein A12, receptor for advanced glycation endproducts, and nuclear factor-κB expression with inflammation in pulp tissues from tooth caries.
    Khorasani MMY; Andam-Shahsavari P; Zainodini N; Khoramdelazad H; Nosratabadi R
    J Investig Clin Dent; 2018 Feb; 9(1):. PubMed ID: 28834384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients.
    Jung ES; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
    J Korean Med Sci; 2017 Jan; 32(1):54-59. PubMed ID: 27914132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A12-CD36 axis: A novel player in the pathogenesis of atherosclerosis?
    Farokhzadian J; Mangolian Shahrbabaki P; Bagheri V
    Cytokine; 2019 Oct; 122():154104. PubMed ID: 28756107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A12 inhibits fibroblast migration via the receptor for advanced glycation end products and p38 MAPK signaling.
    Tanaka N; Ikari J; Anazawa R; Suzuki M; Katsumata Y; Shimada A; Suzuki E; Matsuura Y; Kawata N; Tada Y; Tatsumi K
    In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):656-664. PubMed ID: 31297698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxylated N-glycans on RAGE promote S100A12 binding and signaling.
    Srikrishna G; Nayak J; Weigle B; Temme A; Foell D; Hazelwood L; Olsson A; Volkmann N; Hanein D; Freeze HH
    J Cell Biochem; 2010 Jun; 110(3):645-59. PubMed ID: 20512925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast.
    Chiou JW; Fu B; Chou RH; Yu C
    PLoS One; 2016; 11(9):e0162000. PubMed ID: 27598566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation.
    Buhimschi IA; Zhao G; Pettker CM; Bahtiyar MO; Magloire LK; Thung S; Fairchild T; Buhimschi CS
    Am J Obstet Gynecol; 2007 Feb; 196(2):181.e1-13. PubMed ID: 17306673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS and oxLDL-induced S100A12 and RAGE expression in carotid arteries of atherosclerotic Yucatan microswine.
    Singh H; Rai V; Agrawal DK
    Mol Biol Rep; 2022 Sep; 49(9):8663-8672. PubMed ID: 35771356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein.
    Katte R; Yu C
    PLoS One; 2018; 13(6):e0198767. PubMed ID: 29902210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A12 gene expression is increased in peripheral leukocytes in chronic kidney disease stage 4-5 patients with cardiovascular disease.
    Hara M; Ando M; Morito T; Nokiba H; Iwasa Y; Tsuchiya K; Nitta K
    Nephron Clin Pract; 2013; 123(3-4):202-8. PubMed ID: 23921255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?
    Morbini P; Villa C; Campo I; Zorzetto M; Inghilleri S; Luisetti M
    Mod Pathol; 2006 Nov; 19(11):1437-45. PubMed ID: 16941014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease.
    Zakiyanov O; Kalousová M; Kříha V; Zima T; Tesař V
    Kidney Blood Press Res; 2011; 34(6):457-64. PubMed ID: 21822023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients.
    Torino C; Pizzini P; Cutrupi S; Tripepi R; Vilasi A; Tripepi G; Mallamaci F; Zoccali C
    Oxid Med Cell Longev; 2017; 2017():2801324. PubMed ID: 29362665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction.
    Fuellen G; Foell D; Nacken W; Sorg C; Kerkhoff C
    Trends Immunol; 2003 Dec; 24(12):622-4. PubMed ID: 14644132
    [No Abstract]   [Full Text] [Related]  

  • 19. Human S100A12: a novel key player in inflammation?
    Pietzsch J; Hoppmann S
    Amino Acids; 2009 Mar; 36(3):381-9. PubMed ID: 18443896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of S100A12 in the pathogenesis of osteoarthritis.
    Nakashima M; Sakai T; Hiraiwa H; Hamada T; Omachi T; Ono Y; Inukai N; Ishizuka S; Matsukawa T; Oda T; Takamatsu A; Yamashita S; Ishiguro N
    Biochem Biophys Res Commun; 2012 Jun; 422(3):508-14. PubMed ID: 22609404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.